These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6891756)

  • 1. Glutamic acid diethyl ester induces catalepsy in rats. A new model for schizophrenia?
    Kornhuber J; Fischer EG
    Neurosci Lett; 1982 Dec; 34(3):325-9. PubMed ID: 6891756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
    Geffen Y; Nudelman A; Gil-Ad I; Rephaeli A; Huang M; Savitsky K; Klapper L; Winkler I; Meltzer HY; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):1-13. PubMed ID: 18757185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of l-glutamic acid diethyl ester on discrimination learning in rats.
    Lalonde R
    Eur J Pharmacol; 1990 Nov; 190(1-2):235-8. PubMed ID: 2076756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy.
    Yoshida Y; Ono T; Kizu A; Fukushima R; Miyagishi T
    Eur J Pharmacol; 1991 Oct; 203(2):173-80. PubMed ID: 1686859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
    Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychotropic effects of glutamic acid diethyl ester in mice].
    Kovalev GV; Sazhin VA; Ianitskaia AV
    Biull Eksp Biol Med; 1989 Sep; 108(9):302-4. PubMed ID: 2611385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
    Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
    Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats.
    Pulvirenti L; Swerdlow NR; Koob GF
    Neurosci Lett; 1989 Aug; 103(2):213-8. PubMed ID: 2771183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
    Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of instrumental learning in rats by glutamic acid diethyl ester.
    Freed WJ; Wyatt RJ
    Pharmacol Biochem Behav; 1981 Feb; 14(2):223-6. PubMed ID: 7208561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
    Akhtar M; Uma Devi P; Ali A; Pillai KK; Vohora D
    Fundam Clin Pharmacol; 2006 Aug; 20(4):373-8. PubMed ID: 16867021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
    Sukul NC; Klemm WR
    Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice.
    Kilic FS; Kulluk D; Musmul A
    Neurosciences (Riyadh); 2014 Apr; 19(2):100-5. PubMed ID: 24739405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral glutamate, neuroleptic drugs and schizophrenia: increase of cerebrospinal fluid glutamate levels and decrease of striate body glutamate levels following sulpiride treatment in rats.
    Kim JS; Claus D; Kornhuber HH
    Eur Neurol; 1983; 22(5):367-70. PubMed ID: 6138256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantia nigra and motor control in the rat: effect of intranigral alpha-kainate and gamma-D-glutamylaminomethylsulphonate on motility.
    Turski L; Klockgether T; Turski W; Schwarz M; Sontag KH
    Brain Res; 1987 Oct; 424(1):37-48. PubMed ID: 3690302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia.
    Boeckler F; Russig H; Zhang W; Löber S; Schetz J; Hübner H; Ferger B; Gmeiner P; Feldon J
    Psychopharmacology (Berl); 2004 Aug; 175(1):7-17. PubMed ID: 15007532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.